Number of the records: 1  

Tolcapone: COMT [Catechol O-methyltransferase] inhibition for the treatment of Parkinson's disease

  1. SYSc022203
    LBL
      
    ^^^^^nam^^22^^^^^^^^450^
    005
      
    20040120105913.0
    100
      
    $a 19980624d1998 u y0sloc0103 ba
    101
    0-
    $a eng
    102
      
    $a US
    105
      
    $a y z 000yy
    200
    1-
    $a Tolcapone: COMT [Catechol O-methyltransferase] inhibition for the treatment of Parkinson's disease $f edit. Stanley Fahn
    210
      
    $a Hagerstown $c Lippincott-Raven Publishers $d 1998
    215
      
    $a 59 s.
    225
    2-
    $a Neurology $v Suppl. 5 $x 0028-3878
    541
    1-
    $a Tolcapone: inhibícia katechol-O-metyltransferázy v terapii Parkinsonovej choroby $z slo
    606
      
    $a Parkinsonova choroba $x farmakoterapia $2 mesh $3 sllk_un_auth*d010300
    606
      
    $a katechol-O-metyltransferáza $x antagonisty a inhibítory $x použitie terapeutické $2 mesh $3 sllk_un_auth*d002394
    606
      
    $a levodopa $x použitie terapeutické $x farmakológia $2 mesh $3 sllk_un_auth*d007980
    606
      
    $a katechol-O-metyltransferáza $x antagonisty a inhibítory $x farmakokinetika $2 mesh $3 sllk_un_auth*d002394
    606
      
    $3 sllk_un_auth*d015337 $a štúdie multicentrické ako téma $2 mesh
    675
      
    $a 616.858-085:615.213.03 $v 1. stred. $z slo
    702
    -1
    $a Fahn $b Stanley $3 sllk_un_auth*p0001807 $4 340
    710
    02
    $3 sllk_un_auth*k0000007 $a American Academy of Neurology $4 070
    801
    -0
    $a SK $b BA006 $c 19981223 $g AACR2

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.